Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten-deleted Mouse Models of Sarcoma

Overview of attention for article published in Clinical Cancer Research, September 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Readers on

mendeley: 11 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 8,396 followers.

David Kirsch @DukeMedSchool speaks today about genetically engineered mouse models to study sarcoma. ICYMI- Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten-deleted Sarcoma Models #AACRsarcoma22…

Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten-deleted Mouse Models of Sarcoma https://t.co/VVFrKMZWPL

Tumor subtype determines therapeutic response to chimeric polypeptide nanoparticle-based chemotherapy in Pten-deleted mouse models of sarcoma https://t.co/vizFEKHt1p

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.